Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M, Thariat J, Ouali M, Bouvier C, Decouvelaere AV, Cassagnau E, Aubert S, Lepreux S, Coindre JM, Valmary-Degano S, Larousserie F, Meilleroux J, Projetti F, Stock N, Galant C, Marie B, Peyrottes I, de Pinieux G, Gomez-Brouchet A. Guérin M, et al. Among authors: galant c. Hum Pathol. 2016 Apr;50:70-8. doi: 10.1016/j.humpath.2015.11.012. Epub 2015 Dec 9. Hum Pathol. 2016. PMID: 26997440
[Histological diagnosis of bone tumors: Guidelines of the French committee of bone pathologists reference network on bone tumors (RESOS)].
Galant C, Bouvier C, Larousserie F, Aubert S, Audard V, Brouchet A, Marie B, Guinebretière JM, de Pinieux du Bouexic G; Groupe de Pathologistes du réseau INCA d’expertise pour les sarcomes osseux de RESOS. Galant C, et al. Bull Cancer. 2018 Apr;105(4):368-374. doi: 10.1016/j.bulcan.2017.11.018. Epub 2018 Mar 11. Bull Cancer. 2018. PMID: 29540287 Review. French.
[Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
Macagno N, Caselles K, Aubert S, Audard V, Gomez-Brouchet A, Galant C, Guinebretière JM, Karanian M, Larousserie F, Marie B, de Pinieux G, Bouvier C. Macagno N, et al. Among authors: galant c. Ann Pathol. 2018 Apr;38(2):92-102. doi: 10.1016/j.annpat.2018.01.008. Epub 2018 Mar 23. Ann Pathol. 2018. PMID: 29580573 Review. French.
Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS).
Gomez-Brouchet A, Mascard E, Siegfried A, de Pinieux G, Gaspar N, Bouvier C, Aubert S, Marec-Bérard P, Piperno-Neumann S, Marie B, Larousserie F, Galant C, Fiorenza F, Anract P, Sales de Gauzy J, Gouin F; GROUPOS (GSF-GETO RESOS). Gomez-Brouchet A, et al. Among authors: galant c. Orthop Traumatol Surg Res. 2019 Jun;105(4):773-780. doi: 10.1016/j.otsr.2018.12.015. Epub 2019 Apr 5. Orthop Traumatol Surg Res. 2019. PMID: 30962172 Free article. Review.
Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples.
Miquelestorena-Standley E, Jourdan ML, Collin C, Bouvier C, Larousserie F, Aubert S, Gomez-Brouchet A, Guinebretière JM, Tallegas M, Brulin B, Le Nail LR, Tallet A, Le Loarer F, Massiere J, Galant C, de Pinieux G. Miquelestorena-Standley E, et al. Among authors: galant c. Mod Pathol. 2020 Aug;33(8):1505-1517. doi: 10.1038/s41379-020-0503-6. Epub 2020 Feb 24. Mod Pathol. 2020. PMID: 32094425 Free article.
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers.
Richer W, Masliah-Planchon J, Clement N, Jimenez I, Maillot L, Gentien D, Albaud B, Chemlali W, Galant C, Larousserie F, Boudou-Rouquette P, Leruste A, Chauvin C, Han ZY, Coindre JM, Varlet P, Freneaux P, Ranchère-Vince D, Delattre O, Bourdeaut F. Richer W, et al. Among authors: galant c. Oncotarget. 2017 May 23;8(21):34245-34257. doi: 10.18632/oncotarget.15939. Oncotarget. 2017. PMID: 28427232 Free PMC article.
168 results